A Qualitative Analysis to Explore Factors Influencing Patient Adherence to Prescribed OAB Medication, in UK Primary Care.
Research type
Research Study
Full title
A Qualitative Analysis to Explore Factors Influencing Patient Adherence to Prescribed OAB Medication, in UK Primary Care.
IRAS ID
198502
Contact name
Maxine Holt
Contact email
Sponsor organisation
Manchester Metropolitan University
Duration of Study in the UK
2 years, 0 months, 1 days
Research summary
This research is being carried out as part of The UK Knowledge Transfer Partnership (KTP) programme (Europe’s leading programme for helping businesses to innovate, develop, and grow through better use of the knowledge, technology, and skills that reside within the UK knowledge base). The research partners are Manchester Metropolitan University (MMU) and Astellas Pharma Europe Limited (APEL). \n\nNon-adherence to drug-taking protocols has a major negative impact on ultimate health outcomes, and the effectiveness of treatment pathways is not solely a function of the drugs in use. According to the World Health Organisation, non-adherence accounts for 80% of the difference between Randomised Control Trial (RCT) outcomes and real-world effectiveness. This research aims to explore non-pharma issues, which influence patient adherence to medications for Over Active Bladder (OAB). A greater understanding of these non-pharma issues has the potential to drive the development of personalised value-added services and, guide new product and service development that could significantly improve health outcomes in target patient groups. This approach to stratified medicine is highly innovative and potentially ground breaking. In addition to the development of new products, the research will also contribute to the teaching and learning of health professions, the development of healthcare policy and practice and improve access to, and quality of, healthcare by providing cost-effective treatment interventions for people with Over Active Bladder(OAB).Patients who fall into the category of taking medications for the above condition will be recruited from Primary Care Services. The study will last two years. This is a qualitative study and will utilise qualitative methods such as questionnaires, surveys, focus groups, face-to-face and telephone interviews. \n\n\n\n
REC name
North West - Liverpool Central Research Ethics Committee
REC reference
16/NW/0724
Date of REC Opinion
27 Sep 2016
REC opinion
Favourable Opinion